US-based medical equipment maker Medtronic has received clearance from antitrust authorities in China and South Korea to acquire Ireland-based Covidien for nearly $43 billion, according to reports.
Medtronic expects to close the deal in early 2015 but is already making headlines from the transaction; according to reports, Metronic announced only days ago that it sold $17 billion in commercial bonds to finance its acquisition – the largest sale of debt by a corporation in 2014.
China’s Ministry of Commerce and South Korea’s Fair Trade Commission are the latest of 12 competition authorities across the globe to approve of the deal. Regulators in the US and EU have similarly cleared the takeover.
While antitrust watchdogs have presented little resistance to the deal, Medtronic’s acquisition of Covidien has raised concerns due to Medtronic’s plans to relocate its headquarters to Ireland, allowing the company to benefit from lower taxes. Such inversion mergers have become the focus of scrutiny in several jurisdictions, including in the US and EU.
Full content: Daily Telegraph
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
EU to Scrutinize Telecom Italia’s Network Sale to KKR
May 8, 2024 by
CPI
Turkey Hits Meta with $37.20 Million Fine Over Data-Sharing Practices
May 8, 2024 by
CPI
Google Seeks Dismissal of UK Suit Over Alleged Anti-Competitive Practices
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI